<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6143276</article-id><article-id pub-id-type="pmid">30188905</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0006738</article-id><article-id pub-id-type="publisher-id">PNTD-D-18-00816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Processes</subject><subj-group><subject>Evolutionary Rate</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Organismal Evolution</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Microbial Genomics</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Genomics</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>RNA sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>RNA sequencing</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Genome Sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Genome Sequencing</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Angola</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Nucleotide Sequencing</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Nucleotide Sequencing</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Phylogenomic analysis unravels evolution of yellow fever virus within hosts</article-title><alt-title alt-title-type="running-head">Intrahost phylogenomics of yellow fever virus</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1765-8899</contrib-id><name><surname>Chen</surname><given-names>Chen</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jiang</surname><given-names>Dong</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ni</surname><given-names>Ming</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Jing</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhihai</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jingyuan</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Hanhui</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Gary</given-names></name><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Wei</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuanyuan</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3746-0188</contrib-id><name><surname>Wang</surname><given-names>Beibei</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bi</surname><given-names>Yuhai</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Danying</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ping</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Xuesen</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kong</surname><given-names>Yaxian</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Weifeng</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Pengcheng</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Gengfu</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Juncai</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>George F.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff010"><sup>10</sup></xref><xref ref-type="aff" rid="aff011"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Jie</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Fujie</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wenjun</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff010"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bo</surname><given-names>Xiaochen</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ang</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Hui</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3693-2726</contrib-id><name><surname>Liu</surname><given-names>Di</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff009"><sup>9</sup></xref><xref ref-type="aff" rid="aff010"><sup>10</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Beijing Institute of Radiation Medicine, Beijing, China</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Institute of Microbiology, Chinese Academy of Sciences, Beijing, China</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Clinical Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Department of Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, China</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Fuzhou Infectious Disease Hospital of Fujian Medical University, Fuzhou, China</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Institute of Pathogen Biology, Taishan Medical College, Taian, China</addr-line></aff><aff id="aff009"><label>9</label>
<addr-line>Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China</addr-line></aff><aff id="aff010"><label>10</label>
<addr-line>Medical School, University of Chinese Academy of Sciences, Beijing, China</addr-line></aff><aff id="aff011"><label>11</label>
<addr-line>Chinese Center for Disease Control and Prevention (China CDC), Beijing, China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Mossel</surname><given-names>Eric</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Center for Disease Control and Prevention, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>liud@wh.iov.cn</email> (DL); <email>zenghui@ccmu.edu.cn</email> (HZ); <email>chenchen1@ccmu.edu.cn</email> (CC); <email>liang@ccmu.edu.cn</email>) (AL)</corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2018</year></pub-date><volume>12</volume><issue>9</issue><elocation-id>e0006738</elocation-id><history><date date-type="received"><day>22</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>7</day><month>8</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Chen et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0006738.pdf"/><abstract><p>The yellow fever virus (YFV) recently reemerged in the large outbreaks in Africa and Brazil, and the first imported patients into Asia have recalled the concerns of YFV evolution. Here we show phylogenomics of YFV with serial clinical samples of the 2016 YFV infections. Phylogenetics exhibited that the 2016 strains were close to Angola 1971 strains and only three amino acid changes presented new to other lineages. Deep sequencing of viral genomes discovered 101 intrahost single nucleotide variations (iSNVs) and 234 single nucleotide polymorphisms (SNPs). Analysis of iSNV distribution and mutated allele frequency revealed that the coding regions were under purifying selection. Comparison of the evolutionary rates estimated by iSNV and SNP showed that the intrahost rate was ~2.25 times higher than the epidemic rate, and both rates were higher than the long-term YFV substitution rate, as expected. In addition, the result also hinted that short viremia duration of YFV might further hinder the evolution of YFV.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>The first importation of infections into China in 2016 and the following outbreaks in Africa and Brazil of yellow fever virus (YFV) have raised again the concerns of the potential viral spread into new territories. In this study, we aimed to know the evolution dynamics of YFV by using intrahost phylogenomics and to assess the risk of virus epidemics. Through deep sequencing of consecutive samples from 12 patients, we identified hundreds of genomic variations (iSNVs and SNPs), and noticed the nearly linear accumulation of variations within individuals. The estimated evolutionary rate within host is much higher than the epidemic evolutionary rate. In comparison with Dengue virus (DENV) and Zika virus (ZIKV), which share similar host vectors (Aedes spp.), life cycles, mutation rates and replication strategies to YFV, the lower epidemic evolutionary rate of YFV might have been hindered by the shorter viremia duration, which decreased the accumulated variations to get into the transmission cycle.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Beijing Municipal Science &#x00026; Technology Commission</institution></funding-source><award-id>Z161100000116049</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Ang</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by Grants from China Ministry of Science and Technology Key Research and Development Program [2016YFC1200804 and 2016YFC1200805], Beijing Municipal Science &#x00026; Technology Commission [Z161100000116049], National Natural Science Foundation of China [91631110 and U1435222], Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201602NHFPC], Beijing Nova program [Z161100004916101, Z181100006218114], Beijing 215 Project [2015-3-107], China National Grand S&#x00026;T Special Project [2016ZX10004222-010], and &#x02018;863&#x02019; Program [2015AA020108 &#x00026; 2014AA021501]. WS is supported by the &#x02018;Taishan Scholar&#x02019; project of Shandong Province. GW is supported by the President&#x02019;s International Fellowship Initiative from CAS. JC is supported by CAS Pioneer Hundred Talents Program. GFG is a leading principal investigator of the NSFC Innovative Research Group [81321063]. DL is supported by National Program for Support of Top-notch Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="15"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2018-09-18</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All reads from next generation sequencing were deposited in the NCBI SRA database under the accession no. SRP096859. The genome sequences of YF-BJ1, YF-BJ2, YF-BJ3, YF-BJ4, YF-BJ5, YF-FZ2, YF-FZ4, YF-FZ6, and YF-FZ7 were deposited in the NCBI GenBank database under the accession no. MH633684-MH633692.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All reads from next generation sequencing were deposited in the NCBI SRA database under the accession no. SRP096859. The genome sequences of YF-BJ1, YF-BJ2, YF-BJ3, YF-BJ4, YF-BJ5, YF-FZ2, YF-FZ4, YF-FZ6, and YF-FZ7 were deposited in the NCBI GenBank database under the accession no. MH633684-MH633692.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Yellow fever is a notorious mosquito-borne viral disease emerged during the 15th-19th centuries in the Americas, Africa and Europe, causing severe hemorrhagic fever and liver injury with high mortality rates. Although control of mosquitoes and the use of the live-attenuated yellow fever virus (YFV)-17D vaccine strain have effectively prevented and controlled the epidemics, YFV is estimated to cause approximately 30,000 deaths out of 200,000 infections annually worldwide, mostly in Africa (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/">https://www.cdc.gov</ext-link>, last accessed 10<sup>th</sup> April, 2018). The etiological agent of the disease, YFV, is a single-stranded, positive-sense RNA virus with a ~11 kb genome in length. The virus is frequently transmitted between nonhuman primates and mosquitoes in African and American jungles, known as the sylvatic cycle [<xref rid="pntd.0006738.ref001" ref-type="bibr">1</xref>]. Occasionally, YFV can escape from the sylvatic cycle to infect humans, with subsequent transmission between mosquitoes and humans, forming the urban cycle. Historically, YFV was believed to have originated from Central or East Africa, and transmitted to America during the slave trade [<xref rid="pntd.0006738.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0006738.ref003" ref-type="bibr">3</xref>]. Currently, YFV in Africa and America are classified into seven genotypes, with two in South America, two in West Africa, and three in East and Central Africa [<xref rid="pntd.0006738.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0006738.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0006738.ref005" ref-type="bibr">5</xref>].</p><p>In January 2016, the Ministry of Health of Angola notified the World Health Organization (WHO) of a yellow fever disease outbreak: as of October 28<sup>th</sup>, 4,347 suspected cases, including 377 deaths, were reported from all 18 provinces of Angola. Outbreaks were also reported simultaneously from the Democratic Republic of Congo and Uganda [<xref rid="pntd.0006738.ref006" ref-type="bibr">6</xref>]. In February 2018, 464 confirmed human cases of yellow fever have also been reported in Brazil, with 154 deaths (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/">http://www.who.int</ext-link>, last accessed 10<sup>th</sup> April, 2018). Meanwhile, epizootics have expanded to areas previously not considered at risk for yellow fever (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/27-february-2018-yellow-fever-brazil/en/">http://www.who.int/csr/don/27-february-2018-yellow-fever-brazil/en/</ext-link>, last accessed on 10<sup>th</sup> April, 2018). All these recalled the concerns of the evolution of YFV. During the Angolan outbreak, YFV infections were detected in Chinese workers returning to China from Angola [<xref rid="pntd.0006738.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pntd.0006738.ref009" ref-type="bibr">9</xref>], marking the first time YFV infections were documented in Asia. By using the consecutive samples from those imported YFV patients, we unraveled the intrahost and epidemic evolutionary dynamics of YFV.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Deep sequencing of YFV genomes from clinical samples</title><p>We collected samples from twelve out of thirteen YFV patients in China, sequenced the viral genomes, and performed analyses on phylogenetics, sequence comparison, and intra-host dynamics. Of the 12 patients, two had severe disease, in which one survived (YF-BJ3) and one died (YF-BJ1), and the remaining patients displayed mild symptoms (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref></italic>). We tested blood samples of these 12 patients from the first day of admittance to the hospital by real-time reverse transcription PCR (RT-PCR), and four patients (YF-BJ1, YF-BJ2, YF-BJ3, and YF-BJ5) were positive. YFV RNA fragments could be detected in serum until 9, 12, 10 and 6 days, respectively, after the onset of symptoms (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref>, and <xref ref-type="fig" rid="pntd.0006738.g001">Fig 1</xref></italic>). Urine samples from all patients were also tested by real-time RT-PCR and all were YFV-positive. Higher viral RNA loads were observed in the urine compared to the blood samples, except for those from the non-survivor (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref></italic>). The virus persisted in urine samples for at least 15 days after the onset of symptoms in survivors. Specifically, the urine sample from patient YF-BJ3 was still PCR-positive when tested 32 days after the onset of symptoms (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="pntd.0006738.g001">Fig 1</xref></italic>). We then sequenced all available YFV-positive samples by using total RNA sequencing, amplicon sequencing and/or Sanger sequencing (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref> and</italic>
<xref ref-type="supplementary-material" rid="pntd.0006738.s004"><italic>S</italic>1 <italic>Table</italic></xref>). In total, nearly complete virus genomes (&#x0003e;10,222 bp) from 9 patients, and deep-sequenced genome datasets (average sequence depth 34,978x) from 3 patients covering 12 time points were obtained (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref></italic>).</p><fig id="pntd.0006738.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006738.g001</object-id><label>Fig 1</label><caption><title>Cases of twelve documented returning YFV patients in China by date in the outbreak of Angola from March to May 2016.</title><p>Timeline of events for each patient from symptom onset to the leaving from hospital are shown with different molecular detection methods and results. Dots denote that we did not get any positive molecular detection result in the time point, grey (before admitted to hospital) and blue (after admitted to hospital). The larger size dots means that we performed Real-time PCR detections in that point. The red triangles denote the sample have been detected by PCR and Real-time PCR with positive results. Blue boxes denote the samples that were subjected to NGS analysis at the time points.</p></caption><graphic xlink:href="pntd.0006738.g001"/></fig><table-wrap id="pntd.0006738.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006738.t001</object-id><label>Table 1</label><caption><title>Patient information, viral loads and genome sequencing in urine samples.</title></caption><alternatives><graphic id="pntd.0006738.t001g" xlink:href="pntd.0006738.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Patient ID</th><th align="center" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Outcome</th><th align="center" rowspan="1" colspan="1">Days after onset</th><th align="center" rowspan="1" colspan="1">Blood virus (Ct)<xref ref-type="table-fn" rid="t001fn001">*</xref></th><th align="center" rowspan="1" colspan="1">Urine virus (Ct)<xref ref-type="table-fn" rid="t001fn001">*</xref></th><th align="center" rowspan="1" colspan="1">Sequencing Method<xref ref-type="table-fn" rid="t001fn002">&#x02020;</xref></th><th align="center" rowspan="1" colspan="1"># Total Reads</th><th align="center" rowspan="1" colspan="1"># Mapped Reads</th><th align="center" rowspan="1" colspan="1">Sequencing Depth (x1000)</th><th align="center" rowspan="1" colspan="1">Genome Coverage (bp)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">YF-BJ1</td><td align="center" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">Death</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">35.00</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,695,368</td><td align="center" rowspan="1" colspan="1">1,509,993</td><td align="center" rowspan="1" colspan="1">30.98</td><td align="center" rowspan="1" colspan="1">10,732</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">33.50</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,661,085</td><td align="center" rowspan="1" colspan="1">953,063</td><td align="center" rowspan="1" colspan="1">19.67</td><td align="center" rowspan="1" colspan="1">10,650</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">34.42</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">3,303,973</td><td align="center" rowspan="1" colspan="1">1,952,626</td><td align="center" rowspan="1" colspan="1">35.68</td><td align="center" rowspan="1" colspan="1">10,725</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-BJ3</td><td align="center" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">27.6</td><td align="center" rowspan="1" colspan="1">25.60</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,451,105</td><td align="center" rowspan="1" colspan="1">1,354,090</td><td align="center" rowspan="1" colspan="1">27.59</td><td align="center" rowspan="1" colspan="1">10,650</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">27.9</td><td align="center" rowspan="1" colspan="1">25.32</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,941,400</td><td align="center" rowspan="1" colspan="1">2,369,835</td><td align="center" rowspan="1" colspan="1">18.97</td><td align="center" rowspan="1" colspan="1">10,393</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">32.85</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">4,034,937</td><td align="center" rowspan="1" colspan="1">2,896,728</td><td align="center" rowspan="1" colspan="1">55.05</td><td align="center" rowspan="1" colspan="1">10,405</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">31.66</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,998,163</td><td align="center" rowspan="1" colspan="1">1,861,631</td><td align="center" rowspan="1" colspan="1">36.67</td><td align="center" rowspan="1" colspan="1">10,397</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">34.00</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,920,032</td><td align="center" rowspan="1" colspan="1">1,416,518</td><td align="center" rowspan="1" colspan="1">28.89</td><td align="center" rowspan="1" colspan="1">10,393</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">39.83</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,424,735</td><td align="center" rowspan="1" colspan="1">1,014,331</td><td align="center" rowspan="1" colspan="1">21.80</td><td align="center" rowspan="1" colspan="1">10,650</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-BJ5</td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">23.84</td><td align="center" rowspan="1" colspan="1">23.77</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">2,001,845</td><td align="center" rowspan="1" colspan="1">1,866,672</td><td align="center" rowspan="1" colspan="1">37.82</td><td align="center" rowspan="1" colspan="1">9,918</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">35.42</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,684,026</td><td align="center" rowspan="1" colspan="1">1,014,398</td><td align="center" rowspan="1" colspan="1">18.54</td><td align="center" rowspan="1" colspan="1">10,674</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">34.23</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">2,090,128</td><td align="center" rowspan="1" colspan="1">840,862</td><td align="center" rowspan="1" colspan="1">16.56</td><td align="center" rowspan="1" colspan="1">10,394</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-BJ2</td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">30.95</td><td align="center" rowspan="1" colspan="1">AS</td><td align="center" rowspan="1" colspan="1">1,924,145</td><td align="center" rowspan="1" colspan="1">1,467,048</td><td align="center" rowspan="1" colspan="1">30.21</td><td align="center" rowspan="1" colspan="1">10,398</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-BJ4</td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">35.86</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">56,728,408</td><td align="center" rowspan="1" colspan="1">873</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">10,393</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ1<xref ref-type="table-fn" rid="t001fn004">&#x000a7;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">77,238,978</td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">1,012</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ2<xref ref-type="table-fn" rid="t001fn003">&#x000b6;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">39.37</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">58,570,126</td><td align="center" rowspan="1" colspan="1">195</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">10,243</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ3<xref ref-type="table-fn" rid="t001fn004">&#x000a7;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">39.40</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">50,462,246</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">839</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ4<xref ref-type="table-fn" rid="t001fn003">&#x000b6;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">10,222</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ5<xref ref-type="table-fn" rid="t001fn004">&#x000a7;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">56,605,654</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">2,795</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ6<xref ref-type="table-fn" rid="t001fn003">&#x000b6;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">32.44</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">51,627,058</td><td align="center" rowspan="1" colspan="1">4,722</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">10,838</td></tr><tr><td align="center" rowspan="1" colspan="1">YF-FZ7<xref ref-type="table-fn" rid="t001fn003">&#x000b6;</xref></td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Discharged</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">33.96</td><td align="center" rowspan="1" colspan="1">TS</td><td align="center" rowspan="1" colspan="1">64,345,650</td><td align="center" rowspan="1" colspan="1">3,945</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">10,311</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>* &#x0201c;-&#x0201d;, Negative results (Ct value &#x0003e;45).</p></fn><fn id="t001fn002"><p>&#x02020; AS, amplicon sequencing; TS, total RNA sequencing.</p></fn><fn id="t001fn003"><p>&#x000b6; Genome sequence assembled with Sanger sequencing data.</p></fn><fn id="t001fn004"><p>&#x000a7; Genome sequence failed to assemble.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec004"><title>Phylogenetics and sequence comparison of YFV genome</title><p>We performed phylogenetic analysis of the coding region of YFVs (<xref ref-type="supplementary-material" rid="pntd.0006738.s005">S2 <italic>Table</italic></xref>), and found that YFV sequences from the returning workers in 2016 outbreak closely clustered with the 1971 Angola strains (<italic><xref ref-type="fig" rid="pntd.0006738.g002">Fig 2A</xref></italic>). Of note, the vaccine strain YF-17D and its derivatives are located far from the Angola strains on the phylogenetic tree. A closer inspection of the Angola strains shows that the viruses in the 2016 outbreak are likely from a single origin and genome sequences from both severely ill patients are closely clustered (<italic><xref ref-type="fig" rid="pntd.0006738.g002">Fig 2B</xref></italic>). There are 188 nucleotide substitutions between the 1971 and 2016 consensus sequences and 6 of them are nonsynonymous substitutions. Comparison of the YFV polypeptides shows that only three amino acid changes that appear to be specific to the Angola 2016 strains (<italic><xref ref-type="fig" rid="pntd.0006738.g002">Fig 2C</xref></italic>). Two are in the capsid protein and one in NS5, the RNA-dependent RNA polymerase. The above data are consistent with previous studies using partial or whole genomes showing that YFV exhibits a slow evolutionary rate [<xref rid="pntd.0006738.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0006738.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0006738.ref010" ref-type="bibr">10</xref>].</p><fig id="pntd.0006738.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006738.g002</object-id><label>Fig 2</label><caption><title>Phylogenetics and amino acids comparison of YFV viruses.</title><p>(A) Maximum-likelihood phylogenetic tree of YFV genome sequences (the first 130 bps in 5&#x02019;-UTR and the last 370 bps in 3&#x02019;-UTR sequences are excluded). Bootstrap support values are shown along the branches. Wesselsbron virus, Sepik virus and Entebbe bat virus were used as outgroup. (B) Maximum-likelihood phylogenic tree of YFV genomes of Angola 2016 strains. Viruses from patients with severe disease are highlighted in magenta. Angola 1971(GenBank accession AY968064) was used as outgroup. Bootstrap support values (&#x02265;70) are shown. (C) Comparison of amino acids of YFV consensus sequence of each lineage in (A). Identical amino acid to vaccine strain (17D) lineage is denoted as a dot. The amino acid sites that were different in Angola 2016 and 1971, are highlight with red rectangles. Novel amino acid substitutions of Angola 2016 are denoted by arrowheads.</p></caption><graphic xlink:href="pntd.0006738.g002"/></fig></sec><sec id="sec005"><title>Intrahost genomic variations</title><p>For the deep-sequenced samples, we identified the iSNVs by using methods in a previous study for Ebola virus [<xref rid="pntd.0006738.ref011" ref-type="bibr">11</xref>]. The mean sequencing depth of genomic regions is between 16,558x and 37,822x (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3A</xref></italic>), and a total of 101 iSNV sites were discovered, including 69 in the coding region and 32 in non-coding regions. In each iSNV sites, we only found two types of nucleotides. Taken that sequencing errors are generated randomly and may result in multi-nucleotide heterogeneity in a single site, it is unlikely those iSNVs were the results of sequencing bias. Fewer iSNVs appeared in the 1<sup>st</sup> and 2<sup>nd</sup> codon positions than the 3<sup>rd</sup> codon position (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3B</xref></italic>) and fewer non-synonymous than synonymous iSNVs (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3C</xref></italic>), implying that the coding region is generally under purifying selection. We plotted the distributions of all mutated allele frequencies of the iSNVs (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3D and 3E</xref></italic>). The mean mutated allele frequency of non-coding iSNVs was at 0.18, while that of synonymous and non-synonymous iSNVs was 0.12 and 0.09, respectively (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3D</xref></italic>). Among them, non-synonymous iSNV is significantly lower than that in non-coding regions (P = 0.02). The distribution of non-coding iSNVs is close to the expected neutrality, whereas curves of synonymous and nonsynonymous iSNVs have higher portions of iSNVs in the area of low mutated allele frequencies (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3E</xref></italic>). This further supports the notion that the coding region was under purifying selection. Additionally, we discovered two variant types at the 3&#x02019; untranslated region (UTR), one with 5 concurrent iSNVs (G10360A, U10365G, C10367U, G10373A, and U10398C) and the other having an additional iSNV (A10425G) (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3F</xref></italic>). Phasing analysis reveals that these iSNVs tend to be concurrent in the same reads (<xref ref-type="supplementary-material" rid="pntd.0006738.s006">S3 <italic>Table</italic></xref>
<italic>and <xref ref-type="supplementary-material" rid="pntd.0006738.s001">S1 Fig</xref></italic>). Predicted RNA structure shows that these substitutions are likely to affect the structure of the 3&#x02019; UTR (<italic><xref ref-type="fig" rid="pntd.0006738.g003">Fig 3F</xref> and <xref ref-type="supplementary-material" rid="pntd.0006738.s002">S2 Fig</xref></italic>), and probably influence viral replication in hosts [<xref rid="pntd.0006738.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pntd.0006738.ref014" ref-type="bibr">14</xref>].</p><fig id="pntd.0006738.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006738.g003</object-id><label>Fig 3</label><caption><title>The iSNVs of Angola 2016 YFVs from clinical samples.</title><p>(A) Sequencing depth across the sequenced genomes. The x-axis represents the YFV genome, with the ORF boundaries indicated by vertical dashed lines. The sequencing depth smoothed by locally weighted smooth regression (LOESS) is shown by the black curve, with 95% confidence interval as shown by shadow. (B) Numbers of iSNVs at non-coding (NC) regions and codon positions of the ORF. (C) Numbers of nonsynonymous (N) and synonymous (S) iSNVs of the ORF. (D) Box plots of the mutated allele frequencies (MuAFs) for non-coding, synonymous and nonsynonymous iSNVs. The MuAF values of three kinds of iSNVs are compared to each other with the Wilcoxon rank-sum test. Dashed lines denote the boundaries of MuAFs in iSNV identification. Boxes denote the interquartile range (IQR) between the first and third quartiles. Lines inside the boxes indicate the median, and the lines outside boxes represent values within 1.5 times the IRQ. Outliers are denoted as dots. (E) Comparison of MuAF spectra of non-coding, synonymous and nonsynonymous iSNVs. MuAFs (dots) are shown with LOESS lines (95% confidence interval in shadow). Expectation under neutral selection is shown by a black line. (F) Prediction of RNA secondary structures of 3&#x02019; UTR (with 68 bp downstream of the stop codon). The earliest type of Angola 2016 (wildtype) and two nucleotides variant types are illustrated. Six variation sites are highlighted in magenta. The stop codon is in the gray box.</p></caption><graphic xlink:href="pntd.0006738.g003"/></fig></sec><sec id="sec006"><title>Intrahost evolutionary dynamics</title><p>Subsequently, we placed all of the polymorphic sites (SNPs and iSNVs) along viral genome (<italic><xref ref-type="fig" rid="pntd.0006738.g004">Fig 4A</xref></italic>). SNPs and iSNVs described the viral difference in two levels of between and within the host, respectively. Within 65 days (from the onset of the first patient to the sample of the last patient in this study) we observed a total of 234 SNPs in 148 sites in 18 samples, including 102 synonymous and 117 nonsynonymous SNPs. A total of 138 SNPs that appear only once are scattered along the viral genome. In particular, the SNPs of 5 sites (T900A, A2352C, C3918A, G6463A, and A7320G) could be used to characterize the 2016 YFVs. All five SNPs were detected in seven patients, four SNPs (without A7320G) were detected in one patient (YF-BJ5), and only one patient (YF-BJ3) does not possess any of the above SNPs (<italic><xref ref-type="fig" rid="pntd.0006738.g004">Fig 4A</xref></italic>). Of note, YF-BJ1 is likely a co-infection with more than one YFV variant, as the virus genome on day 7 does not contain any of the five SNPs, whereas all five SNPs became dominant on day 8 (<italic><xref ref-type="fig" rid="pntd.0006738.g004">Fig 4A</xref></italic>). Of the five SNPs, only G6463A is nonsynonymous, resulting in an amino acid substitution from Val to Ile in NS4A.</p><fig id="pntd.0006738.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0006738.g004</object-id><label>Fig 4</label><caption><title>Genomic variations of Angola 2016 YFV and evolutionary model.</title><p>(A) SNPs (in magenta) and iSNVs (in cyan) detected in Angola 2016 strains along the YFV genome. Non-synonymous variations are denoted by ovals, synonymous variations by diamonds, and variations in UTR by rectangles. Non-synonymous site at 6463 is denoted by arrowhead. YFV genome of patient YF-BJ1 at 7 days after the onset (YF-BJ1/7D) was used as the reference sequence (B) Linear regression of number of variations at all variations, synonymous and non-synonymous sites accumulated by days after onset. The smooth shadows denote the LOESS fit with 95% confidence interval.</p></caption><graphic xlink:href="pntd.0006738.g004"/></fig><p>We then compared the accumulation of polymorphic sites within patients over time (<italic><xref ref-type="fig" rid="pntd.0006738.g004">Fig 4B</xref></italic>). Each sample was set to days after onset of the symptoms of the patients it belongs to. Linear regressions revealed that iSNVs and SNPs accumulated from the day of onset of symptoms at a rate of 0.72 and 0.32 variations/day, respectively. The accumulation rate of iSNV may reflect the intrahost evolution. Intriguingly, the YFV evolutionary rate within humans is roughly 2.48 x10<sup>-2</sup> variations/site/year (0.72 variations/day = 0.72 x 365 / 10591 variations/site/year = 2.48 x10<sup>-2</sup> variations/site/year) in our study. Of those synonymous variations, the intrahost evolutionary rate estimated by iSNV was 0.7 x10<sup>-2</sup> variations/site/year; whereas the rate of nonsynonymous variations was 1.2 x10<sup>-2</sup> variations/site/year. Compared to the rates estimated by SNP within these samples, the intrahost evolutionary rate of non-synonymous sites (by iSNV) is higher, while the rate of synonymous sites is slightly higher than the SNP rate.</p></sec></sec><sec sec-type="conclusions" id="sec007"><title>Discussion</title><p>The evolution of YFV is a basic question to unfold to predict the risk of the pathogens. Phylogenetic analysis suggests that the 2016 outbreak is likely the spillover of YFV viruses in Angola. The high identity between the 2016 strain and the vaccine strain YF-17D would explain the effectiveness of the current vaccines [<xref rid="pntd.0006738.ref015" ref-type="bibr">15</xref>]. Although there is a diversity of yellow fever virus genotypes, all genotypes are indistinguishable in serological assays. There is not any evidence that the Angola outbreak was due to immune escape and it is accepted among public health professionals that low vaccine coverage in the area prior to the outbreak was the driving factor and the resulting aggressive mass vaccination campaign was vital for containing and eliminating the outbreak. However, it should be noted that the Angola lineage is clearly diversified from the 17D-lineage (<italic><xref ref-type="fig" rid="pntd.0006738.g002">Fig 2A</xref></italic>). Moreover, we did notice 6 patients who had been vaccinated before [<xref rid="pntd.0006738.ref016" ref-type="bibr">16</xref>], but the limited clinical and epidemiological data cannot tell the immune escape. Future immune escape from current YFV vaccines cannot be fully ruled out, although YFVs evolve very slowly [<xref rid="pntd.0006738.ref017" ref-type="bibr">17</xref>]. A novel vaccine based on a Central/East African YFV isolate would be necessary as a complement vaccine to prepare against future outbreaks. Owing to the slow evolutionary rate and the past experience of using YF-17D, the novel vaccine is likely to work for another decades.</p><p>Virus evolution experienced mutation, selection within and between hosts, genetic drift, and transmission, and finally formed the genetic variants (lineages) over long-term evolutionary timescales [<xref rid="pntd.0006738.ref018" ref-type="bibr">18</xref>]. Deep sequencing of viral genomes can provide novel insights into viral evolutionary dynamics [<xref rid="pntd.0006738.ref019" ref-type="bibr">19</xref>, <xref rid="pntd.0006738.ref020" ref-type="bibr">20</xref>]. In this intra-host phylogenomic analysis, we depicted the evolutionary process of YFV from intra-host to epidemic substitutions, which were reflected by iSNV to SNP, respectively. Other than using the metric for long-term evolutionary rate, we applied the substitution/site/day to measure the intrahost evolutionary rate, which appeared more appropriate in outbreak or epidemic scenarios. Short-term rates may provide better insight into the intrahost YFV evolutionary trends (e.g., iSNV dynamics over time) relative to clinical symptomology, severity, and/or co-morbidities. However, further in vitro or in vivo studies would be needed. The estimated evolutionary rates clearly showed that the intrahost evolutionary rate is ~2.25 times higher than that of the epidemic evolutionary rate, and both are much higher (59 times and 26 times) than the substitution rate of YFV along longer evolutionary timescale [<xref rid="pntd.0006738.ref010" ref-type="bibr">10</xref>]. The higher rate estimated by iSNV reflected purifying selection occurred, when intrahost variations were spreading out. The rates estimated by synonymous iSNV and SNP, respectively, were similar, implying that the synonymous variations were under similar evolutionary constraints during transmission. Meanwhile, only a few of the nonsynonymous variations were spread out in different individuals, and only G6463A (Val to Ile in NS4A) were detected in multiple samples.</p><p>Compard to Dengue virus (DENV) and Zika virus (ZIKV), YFV shares similar host vectors (<italic>Aedes spp</italic>.) and life cycles [<xref rid="pntd.0006738.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0006738.ref022" ref-type="bibr">22</xref>], and has similar mutation rates and replication strategies [<xref rid="pntd.0006738.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0006738.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0006738.ref024" ref-type="bibr">24</xref>]. However, the long-term substitution rates of DENV (0.77&#x02013;0.99 x10<sup>-3</sup> substitutions/site/year) and ZIKA (0.98&#x02013;1.06 x10<sup>-3</sup> substitutions/site/year) are higher than that of YFV [<xref rid="pntd.0006738.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0006738.ref025" ref-type="bibr">25</xref>, <xref rid="pntd.0006738.ref026" ref-type="bibr">26</xref>]. Previous studies have posed that additional constrained selection forces are probably existed [<xref rid="pntd.0006738.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0006738.ref027" ref-type="bibr">27</xref>]. Based on our results, we noticed the nearly linear accumulation of variations within individuals. Since the transmission of YFV variants needs mosquitoes as vector, the window (viremia duration) that mosquitoes could use is essential, as only the variations within this period could be brought into the transmission cycle. A wider window size would possibly allow more non-synonymous variations into the transmission cycle (Cristina Domingo, EID, 2018). Given that YFV, DENV and ZIKV have ~3, 3&#x02013;7, and 4&#x02013;7 days of viremia, respectively, after symptom onset (<italic><xref ref-type="supplementary-material" rid="pntd.0006738.s007">S4 Table</xref></italic>), it hinted that the shorter viremia duration in YFV infections might result in the lower evolutionary rate than that of DENV or ZIKV. Most Flaviviruses are vector-borne viruses and the evolutionary rates in mammals and arthropods are different. The intrahost analysis of virus could show the short-term evolution dynamics, especially from serial samples, and this would be a helpful complement to the long-term evolution of Flaviviruses.</p><p>In addition, deep sequencing and viral genomics have provided new insights into viral evolutionary dynamics, especially in a continuous mode. Our findings strongly suggest that the urine samples should be considered for the clinical diagnosis, genomic surveillance, and large-scale screening of YFV infections. Further investigations are also encouraged to characterize the factors that maintain viremia in vector-borne diseases.</p></sec><sec sec-type="materials|methods" id="sec008"><title>Methods</title><sec id="sec009"><title>Ethics statement</title><p>The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Beijing Ditan Hospital (DSRB 2008/00293 and DSRB 2013/00209). Clinical samples and information were obtained after written informed consents from all participants. All human subjects were adult, and if not, whether a parent or guardian of any child participant provided informed consent on their behalf.</p></sec><sec id="sec010"><title>Patients and data collection</title><p>Twelve YFV patients returning from Angola were recruited (<italic><xref rid="pntd.0006738.t001" ref-type="table">Table 1</xref></italic>). We sampled urine and blood sample of these patients from routine examination and collected their clinical data.</p></sec><sec id="sec011"><title>YFV diagnosis and virus detection</title><p>YFV infection was diagnosed according to the WHO guidelines (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/yellowfev/case-definition/en/">http://www.who.int/csr/disease/yellowfev/case-definition/en/</ext-link>, last accessed 10<sup>th</sup> April, 2018), including clinical symptoms (fever, headache, jaundice, etc.) and laboratory detection of virus by using real-time RT PCR. The serum and urine samples were collected and stored at -80 <sup>o</sup>C for further analyses, including real-time RT-PCR, PCR sequencing and RNA sequencing.</p></sec><sec id="sec012"><title>Next generation sequencing</title><p>RNA from both serum and urine samples were deployed to two approaches of deep sequencing. Approach I: Total RNA sequencing. RNA was purified by Trizol (Thermo Scientific) for each sample, and then total RNA libraries were constructed with 500bps insertion size using the NEBNext UltraTM RNA Library Prep Kit (NEB, MA, USA), and then sequenced by Illumina Hi-seq platform, and generated 2 &#x000d7; 125 bp paired-end reads. Approach II: RNA amplicon sequencing. Two sets of YFV-specific primer pairs were designed (Set A: 5 pairs, amplicon length = 2,248 &#x000b1; 168 nt; Set B: 12 pairs, amplicon length = 1,018 &#x000b1; 48 nt; <xref ref-type="supplementary-material" rid="pntd.0006738.s008">S5 <italic>Table</italic></xref>). PCR products were sequenced by Illumina platform with 2 &#x000d7; 250 bp paired-end reads. Quality control and error correction were implemented according to previous report [<xref rid="pntd.0006738.ref028" ref-type="bibr">28</xref>, <xref rid="pntd.0006738.ref029" ref-type="bibr">29</xref>]. The probably low quality regions in sequencing, including 1) Q&#x0003c;30, and 2) the first 10 bps after primers were removed from the high quality sequences, according to a previous study [<xref rid="pntd.0006738.ref028" ref-type="bibr">28</xref>]. To minimize sequencing error that affects the accuracy of iSNV calling, we only kept the read-pair that has &#x0003e;100 high quality bases in both ends as clean reads. All reads were deposited in the NCBI SRA database under the accession no. SRP096859.</p></sec><sec id="sec013"><title>Sequence alignment and phylogenetic analysis</title><p>Consensus sequences were aligned by MUSCLE [<xref rid="pntd.0006738.ref030" ref-type="bibr">30</xref>]. Phylogenetic analyses were performed by using RAxML v8.1.6, with the GTR model of nucleotide substitution and &#x003b3;-distributed rates among sites. Phylogenetic tree was constructed by maximum-likelihood using YFV genome sequences [<xref rid="pntd.0006738.ref031" ref-type="bibr">31</xref>]. A NJ tree based on YFV genome sequences was also constructed to show the results were robust (<xref ref-type="supplementary-material" rid="pntd.0006738.s003">S3 <italic>Fig</italic></xref>). A total of 1,000 bootstrap replicates were performed. All SNPs were listed in <xref ref-type="supplementary-material" rid="pntd.0006738.s009">S6 <italic>Table</italic></xref>. The genome sequences of YF-BJ1, YF-BJ2, YF-BJ3, YF-BJ4, YF-BJ5, YF-FZ2, YF-FZ4, YF-FZ6, and YF-FZ7 were deposited in the NCBI GenBank database under the accession no. MH633684-MH633692.</p></sec><sec id="sec014"><title>Calling of iSNVs</title><p>To minimize the potential sequencing errors generated by system, we performed the following two steps before we called iSNV, including 1) mapping the clean reads to the reference genome, 2) qualification of the samples. For mapping the clean reads to genome, we use the traditional protocol used widely. First, we mapped the clean reads with pair-ended aligned to the assembled genome from YF-BJ1/7D by using Bowtie2 v2.2.5 [<xref rid="pntd.0006738.ref032" ref-type="bibr">32</xref>] with default parameters. SAMtools v1.2 [<xref rid="pntd.0006738.ref033" ref-type="bibr">33</xref>] was used to generate &#x02018;mpileup&#x02019; files with no limit for the maximum site depth. To find the potential mutation in each site, we do not use the following pipeline in SAMtools. Instead, we developed homemade PERL scripts (available at <ext-link ext-link-type="uri" xlink:href="http://github.com/generality/iSNV-calling/">http://github.com/generality/iSNV-calling/</ext-link>), which were used for iSNV calling to identify all potential mutations by using the mpileup files as input. The depth of bases in each sites were used to measure the mutation rate of iSNV. Then, we selected the samples with more than 3,000 sites with a sequencing depth &#x02265;300&#x000d7; as candidate samples for iSNV calling. Using this protocol, we called iSNV in 15 samples in this study (<xref ref-type="supplementary-material" rid="pntd.0006738.s004">S1 <italic>Table</italic></xref>), and obtained the frequencies of each allele in each genome site. Interestingly, we only found the heterogeneous nucleotides with two types in each sites. Thus, we defined the nucleotide with higher frequencies as the major allele, and fewer one as the minor allele in the following iSNV calling.</p><p>The iSNV calling was according to the site depth and strand bias with following: 1) remove the ambiguous iSNV and keep the following iSNVs: (1.1) minor allele frequency of &#x02265;5%, a conservative cutoff based on an error rate estimation described before [<xref rid="pntd.0006738.ref011" ref-type="bibr">11</xref>, <xref rid="pntd.0006738.ref028" ref-type="bibr">28</xref>]; (1.2) depth of the minor allele of &#x02265;15; and (1.3) strand bias of the minor allele less than tenfold. 2) In our analysis, these two types of nucleotides in each site have contained the nucleotide in the reference genome. Mutated allele frequencies were calculated by the rate of the reads numbers for mutated alleles to the references and total reads. Minor allele and Major allele frequencies were calculated by the majority nucleotides and minor nucleotides in each site respectively. 3) The effect of iSNV to the gene was calculated by the mutation whether caused the amino acid changes.</p></sec><sec id="sec015"><title>Phasing analysis of iSNVs</title><p>The iSNVs that co-occurred in same viral haplotype(s) within quasispecies was defined as phased iSNVs. 1)We screened the iSNV sites along genome with a window of 250 bp, and then identified all the windows which probably containing a phasing iSNVs. 2) All the sequencing reads aligned to YFV genome region harboring these iSNVs were extracted. 3) The stretches of nearest iSNV were determined by the mutations in the reads aligned to the genome region with the same phasing (supporting reads &#x0003e; = 2). 4) The fractions of reads supporting phased and non-phased neighbor iSNVs were respectively calculated.</p></sec><sec id="sec016"><title>Prediction of RNA secondary structures</title><p>RNA secondary structures were predicted by using RNAfold program of ViennaRNA Package 2 with default settings [<xref rid="pntd.0006738.ref034" ref-type="bibr">34</xref>]. Nucleotide sequences started at the beginning of 3' UTRs of Angola 2016 strain. The length of window for secondary structure prediction was equal to 70 nucleotides. We also extended the additional 200 nucleotides at the end of the sequence, with a step length equal to 50.</p></sec><sec id="sec017"><title>Accession numbers</title><p>All reads from next generation sequencing were deposited in the NCBI SRA database under the accession no. SRP096859. The genome sequences of YF-BJ1, YF-BJ2, YF-BJ3, YF-BJ4, YF-BJ5, YF-FZ2, YF-FZ4, YF-FZ6, and YF-FZ7 were deposited in the NCBI GenBank database under the accession no. MH633684-MH633692.</p></sec></sec><sec sec-type="supplementary-material" id="sec018"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0006738.s001"><label>S1 Fig</label><caption><title>Phasing analysis of iSNVs at the 3&#x02019; untranslated region (UTR).</title><p>For a given sample, the sequencing reads aligned to 3&#x02019; UTR of the YFV genome were extracted to obtain the 5-mutations (at positions 10360, 10365, 10367, 10373 and 10398) or 6-mutations (10360, 10365, 10367, 10373, 10398 and 10425). The pie charts denote fractions of reads supporting wildtype 5/6-mers and phased mutant 5/6-mers (A10360G, G10365T, T10367C, A10373G, C10398T and G10425A), with read counts (or depth, x) shown in brackets. Sample IDs are indicated at the top of pie charts.</p><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s002"><label>S2 Fig</label><caption><title>RNA secondary structure prediction of the 3&#x02019; UTR.</title><p>RNA secondary structures were predicted based on sequences of YFV 3&#x02019; UTR (started from the stop codon) with gradually increased lengths. The sequences were extracted from genomes of wild type Angola 2016 strain and two variant types. Blue arrows indicate variations corresponding to the phased iSNV sites at 3&#x02019; UTR, A10360G, G10365T, T10367C, A10373G, C10398T and G10425A. The local structural alterations due to the variations are highlighted in blue shadow.</p><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s003"><label>S3 Fig</label><caption><title>Phylogenetic tree constructed by neighbor-joining method using YFV genome sequences.</title><p>Viruses from patients with severe disease are highlighted in magenta. Angola 1971(GenBank accession AY968064) was used as outgroup. Bootstrap support values over 70 are shown.</p><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s004"><label>S1 Table</label><caption><title>Sequencing data from continuous clinical samples of YFV.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s005"><label>S2 Table</label><caption><title>Public sequences used for phylogenic analysis.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s005.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s006"><label>S3 Table</label><caption><title>Phasing analysis for continuous neighbor iSNV.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s006.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s007"><label>S4 Table</label><caption><title>Duration of viremia and evolutionary rates of YFV, ZIKV and DENV.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s007.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s008"><label>S5 Table</label><caption><title>Two primer sets used for amplicon-sequencing.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s008.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0006738.s009"><label>S6 Table</label><caption><title>SNPs observed in YFV.</title><p>(PDF)</p></caption><media xlink:href="pntd.0006738.s009.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Prof. Dr. Gong Cheng from Tsinghua University and Prof. Dr. Bo Zhang from Wuhan Institute of Virology, Chinese Academy of Sciences, for helpful discussion.</p></ack><ref-list><title>References</title><ref id="pntd.0006738.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Visser</surname><given-names>LG</given-names></name>, <name><surname>Roukens</surname><given-names>AH</given-names></name>. <article-title>Modelling a way out of yellow fever</article-title>. <source>Lancet</source>
<year>2016</year>; <volume>388</volume>:<fpage>2847</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31330-7</pub-id>
<?supplied-pmid 27837922?><pub-id pub-id-type="pmid">27837922</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Bryant</surname><given-names>JE</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>, <name><surname>Barrett</surname><given-names>AD</given-names></name>. <article-title>Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas</article-title>. <source>PLoS pathogens</source>
<year>2007</year>; <volume>3</volume>:<fpage>e75</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.0030075</pub-id>
<?supplied-pmid 17511518?><pub-id pub-id-type="pmid">17511518</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Mutebi</surname><given-names>J-P</given-names></name>, <name><surname>Rijnbrand</surname><given-names>RC</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3&#x02032; noncoding region</article-title>. <source>Journal of virology</source>
<year>2004</year>; <volume>78</volume>:<fpage>9652</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.18.9652-9665.2004</pub-id>
<?supplied-pmid 15331698?><pub-id pub-id-type="pmid">15331698</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Stock</surname><given-names>NK</given-names></name>, <name><surname>Laraway</surname><given-names>H</given-names></name>, <name><surname>Faye</surname><given-names>O</given-names></name>, <name><surname>Diallo</surname><given-names>M</given-names></name>, <name><surname>Niedrig</surname><given-names>M</given-names></name>, <name><surname>Sall</surname><given-names>AA</given-names></name>. <article-title>Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa</article-title>. <source>Journal of virology</source>
<year>2013</year>; <volume>87</volume>:<fpage>2895</fpage>&#x02013;<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01116-12</pub-id>
<?supplied-pmid 23269797?><pub-id pub-id-type="pmid">23269797</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Vasconcelos</surname><given-names>PF</given-names></name>, <name><surname>Bryant</surname><given-names>JE</given-names></name>, <name><surname>da Rosa</surname><given-names>APT</given-names></name>, <name><surname>Tesh</surname><given-names>RB</given-names></name>, <name><surname>Rodrigues</surname><given-names>SG</given-names></name>, <name><surname>Barrett</surname><given-names>AD</given-names></name>. <article-title>Genetic divergence and dispersal of yellow fever virus, Brazil</article-title>. <source>Emerging infectious diseases</source>
<year>2004</year>; <volume>10</volume>:<fpage>1578</fpage>
<pub-id pub-id-type="doi">10.3201/eid1009.040197</pub-id>
<?supplied-pmid 15498159?><pub-id pub-id-type="pmid">15498159</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>Reiner</surname><given-names>RC</given-names><suffix>Jr.</suffix></name>, <etal>et al</etal>
<article-title>Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015&#x02013;16: a modelling study</article-title>. <source>The Lancet infectious diseases</source>
<year>2016</year>.</mixed-citation></ref><ref id="pntd.0006738.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Lv</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>A fatal yellow fever virus infection in China: description and lessons</article-title>. <source>Emerg Microbes Infect</source>
<year>2016</year>; <volume>5</volume>:<fpage>e69</fpage>
<pub-id pub-id-type="doi">10.1038/emi.2016.89</pub-id>
<?supplied-pmid 27406389?><pub-id pub-id-type="pmid">27406389</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Ling</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Huang</surname><given-names>Q</given-names></name>, <etal>et al</etal>
<article-title>Yellow Fever in a Worker Returning to China from Angola, March 2016</article-title>. <source>Emerging infectious diseases</source>
<year>2016</year>; <volume>22</volume>:<fpage>1317</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid2207.160469</pub-id>
<?supplied-pmid 27314417?><pub-id pub-id-type="pmid">27314417</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>P</given-names></name>, <name><surname>Fu</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Yellow fever virus: Increasing imported cases in China</article-title>. <source>The Journal of infection</source>
<year>2016</year>; <volume>73</volume>:<fpage>377</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2016.07.003</pub-id>
<?supplied-pmid 27422700?><pub-id pub-id-type="pmid">27422700</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Sall</surname><given-names>AA</given-names></name>, <name><surname>Faye</surname><given-names>O</given-names></name>, <name><surname>Diallo</surname><given-names>M</given-names></name>, <name><surname>Firth</surname><given-names>C</given-names></name>, <name><surname>Kitchen</surname><given-names>A</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>. <article-title>Yellow fever virus exhibits slower evolutionary dynamics than dengue virus</article-title>. <source>Journal of virology</source>
<year>2010</year>; <volume>84</volume>:<fpage>765</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01738-09</pub-id>
<?supplied-pmid 19889759?><pub-id pub-id-type="pmid">19889759</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Ni</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Qian</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Intra-host dynamics of Ebola virus during 2014</article-title>. <source>Nature microbiology</source>
<year>2016</year>; <volume>1</volume>:<fpage>16151</fpage>
<pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.151</pub-id>
<?supplied-pmid 27595345?><pub-id pub-id-type="pmid">27595345</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Proutski</surname><given-names>V</given-names></name>, <name><surname>Gould</surname><given-names>EA</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>. <article-title>Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences</article-title>. <source>Nucleic acids research</source>
<year>1997</year>; <volume>25</volume>:<fpage>1194</fpage>&#x02013;<lpage>202</lpage>. <?supplied-pmid 9092629?><pub-id pub-id-type="pmid">9092629</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Villordo</surname><given-names>SM</given-names></name>, <name><surname>Carballeda</surname><given-names>JM</given-names></name>, <name><surname>Filomatori</surname><given-names>CV</given-names></name>, <name><surname>Gamarnik</surname><given-names>AV</given-names></name>. <article-title>RNA Structure Duplications and Flavivirus Host Adaptation</article-title>. <source>Trends in microbiology</source>
<year>2016</year>; <volume>24</volume>:<fpage>270</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2016.01.002</pub-id>
<?supplied-pmid 26850219?><pub-id pub-id-type="pmid">26850219</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Goz</surname><given-names>E</given-names></name>, <name><surname>Tuller</surname><given-names>T</given-names></name>. <article-title>Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes</article-title>. <source>BMC genomics</source>
<year>2015</year>; <volume>16</volume>:<fpage>S4</fpage>.</mixed-citation></ref><ref id="pntd.0006738.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Beck</surname><given-names>A</given-names></name>, <name><surname>Tesh</surname><given-names>RB</given-names></name>, <name><surname>Wood</surname><given-names>TG</given-names></name>, <name><surname>Widen</surname><given-names>SG</given-names></name>, <name><surname>Ryman</surname><given-names>KD</given-names></name>, <name><surname>Barrett</surname><given-names>AD</given-names></name>. <article-title>Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing</article-title>. <source>The Journal of infectious diseases</source>
<year>2013</year>; <volume>209</volume>:<fpage>334</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit546</pub-id>
<?supplied-pmid 24141982?><pub-id pub-id-type="pmid">24141982</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>R</given-names></name>, <name><surname>Guan</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>SS</given-names></name>, <etal>et al</etal>
<article-title>Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China</article-title>. <source>Emerging infectious diseases</source>
<year>2018</year>; <volume>24</volume>:<fpage>1383</fpage>.</mixed-citation></ref><ref id="pntd.0006738.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Monath</surname><given-names>TP</given-names></name>, <name><surname>Barrett</surname><given-names>AD</given-names></name>. <article-title>Pathogenesis and pathophysiology of yellow fever</article-title>. <source>Adv Virus Res</source>
<year>2003</year>; <volume>60</volume>:<fpage>343</fpage>&#x02013;<lpage>95</lpage>. <?supplied-pmid 14689698?><pub-id pub-id-type="pmid">14689698</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Holmes</surname><given-names>EC</given-names></name>, <name><surname>Dudas</surname><given-names>G</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Andersen</surname><given-names>KG</given-names></name>. <article-title>The evolution of Ebola virus: Insights from the 2013&#x02013;2016 epidemic.</article-title>
<source>Nature</source>
<year>2016</year>; <volume>538</volume>:<fpage>193</fpage>
<pub-id pub-id-type="doi">10.1038/nature19790</pub-id>
<?supplied-pmid 27734858?><pub-id pub-id-type="pmid">27734858</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Bonaldo</surname><given-names>MC</given-names></name>, <name><surname>G&#x000f3;mez</surname><given-names>MM</given-names></name>, <name><surname>dos Santos</surname><given-names>AA</given-names></name>, <etal>et al</etal>
<article-title>Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms</article-title>. <source>Mem&#x000f3;rias do Instituto Oswaldo Cruz</source>
<year>2017</year>; <volume>112</volume>:<fpage>447</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1590/0074-02760170134</pub-id>
<?supplied-pmid 28591405?><pub-id pub-id-type="pmid">28591405</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>McMullan</surname><given-names>LK</given-names></name>, <name><surname>Frace</surname><given-names>M</given-names></name>, <name><surname>Sammons</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Using next generation sequencing to identify yellow fever virus in Uganda</article-title>. <source>Virology</source>
<year>2012</year>; <volume>422</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2011.08.024</pub-id>
<?supplied-pmid 21962764?><pub-id pub-id-type="pmid">21962764</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>H</given-names></name>, <name><surname>Lee</surname><given-names>M</given-names></name>, <name><surname>Jin</surname><given-names>X</given-names></name>. <article-title>Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine</article-title>. <source>Cellular &#x00026; molecular immunology</source>
<year>2016</year>; <volume>13</volume>:<fpage>36</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">26435066</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Tabachnick</surname><given-names>WJ</given-names></name>. <article-title>Climate Change and the Arboviruses: Lessons from the Evolution of the Dengue and Yellow Fever Viruses</article-title>. <source>Annu Rev Virol</source>
<year>2016</year>; <volume>3</volume>:<fpage>125</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-virology-110615-035630</pub-id>
<?supplied-pmid 27482902?><pub-id pub-id-type="pmid">27482902</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>Azevedo Rdo</surname><given-names>S</given-names></name>, <name><surname>Kraemer</surname><given-names>MU</given-names></name>, <etal>et al</etal>
<article-title>Zika virus in the Americas: Early epidemiological and genetic findings</article-title>. <source>Science</source>
<year>2016</year>; <volume>352</volume>:<fpage>345</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf5036</pub-id>
<?supplied-pmid 27013429?><pub-id pub-id-type="pmid">27013429</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Mutebi</surname><given-names>J-P</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Bryant</surname><given-names>JE</given-names></name>, <name><surname>Barrett</surname><given-names>AD</given-names></name>. <article-title>Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa</article-title>. <source>Journal of virology</source>
<year>2001</year>; <volume>75</volume>:<fpage>6999</fpage>&#x02013;<lpage>7008</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.75.15.6999-7008.2001</pub-id>
<?supplied-pmid 11435580?><pub-id pub-id-type="pmid">11435580</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Allicock</surname><given-names>OM</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Tatem</surname><given-names>AJ</given-names></name>, <etal>et al</etal>
<article-title>Phylogeography and population dynamics of dengue viruses in the Americas</article-title>. <source>Molecular biology and evolution</source>
<year>2012</year>; <volume>29</volume>:<fpage>1533</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msr320</pub-id>
<?supplied-pmid 22319149?><pub-id pub-id-type="pmid">22319149</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Goz</surname><given-names>E</given-names></name>, <name><surname>Tsalenchuck</surname><given-names>Y</given-names></name>, <name><surname>Benaroya</surname><given-names>RO</given-names></name>, <etal>et al</etal>
<article-title>Generation and comparative genomics of synthetic dengue viruses</article-title>. <source>BMC bioinformatics</source>
<year>2018</year>; <volume>19</volume>:<fpage>140</fpage>
<pub-id pub-id-type="doi">10.1186/s12859-018-2132-3</pub-id>
<?supplied-pmid 29745863?><pub-id pub-id-type="pmid">29745863</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Woelk</surname><given-names>CH</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name>. <article-title>Reduced positive selection in vector-borne RNA viruses</article-title>. <source>Molecular biology and evolution</source>
<year>2002</year>; <volume>19</volume>:<fpage>2333</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a004059</pub-id>
<?supplied-pmid 12446826?><pub-id pub-id-type="pmid">12446826</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Schirmer</surname><given-names>M</given-names></name>, <name><surname>Ijaz</surname><given-names>UZ</given-names></name>, <name><surname>D'Amore</surname><given-names>R</given-names></name>, <name><surname>Hall</surname><given-names>N</given-names></name>, <name><surname>Sloan</surname><given-names>WT</given-names></name>, <name><surname>Quince</surname><given-names>C</given-names></name>. <article-title>Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform</article-title>. <source>Nucleic acids research</source>
<year>2015</year>; <volume>43</volume>:<fpage>e37</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gku1341</pub-id>
<?supplied-pmid 25586220?><pub-id pub-id-type="pmid">25586220</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Nikolenko</surname><given-names>SI</given-names></name>, <name><surname>Korobeynikov</surname><given-names>AI</given-names></name>, <name><surname>Alekseyev</surname><given-names>MA</given-names></name>. <article-title>BayesHammer: Bayesian clustering for error correction in single-cell sequencing</article-title>. <source>BMC Genomics</source>
<year>2013</year>; <volume>14</volume>
<issue>Suppl 1</issue>:<fpage>S7</fpage>.</mixed-citation></ref><ref id="pntd.0006738.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Edgar</surname><given-names>RC</given-names></name>. <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>. <source>Nucleic acids research</source>
<year>2004</year>; <volume>32</volume>:<fpage>1792</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id>
<?supplied-pmid 15034147?><pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Stamatakis</surname><given-names>A</given-names></name>. <article-title>RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models</article-title>. <source>Bioinformatics</source>
<year>2006</year>; <volume>22</volume>:<fpage>2688</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl446</pub-id>
<?supplied-pmid 16928733?><pub-id pub-id-type="pmid">16928733</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Langmead</surname><given-names>B</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nature methods</source>
<year>2012</year>; <volume>9</volume>:<fpage>357</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
<?supplied-pmid 22388286?><pub-id pub-id-type="pmid">22388286</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>
<year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<?supplied-pmid 19505943?><pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation></ref><ref id="pntd.0006738.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Lorenz</surname><given-names>R</given-names></name>, <name><surname>Bernhart</surname><given-names>SH</given-names></name>, <name><surname>Honer Zu Siederdissen</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>ViennaRNA Package 2.0</article-title>. <source>Algorithms Mol Biol</source>
<year>2011</year>; <volume>6</volume>:<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/1748-7188-6-26</pub-id>
<?supplied-pmid 22115189?><pub-id pub-id-type="pmid">22115189</pub-id></mixed-citation></ref></ref-list></back></article>